Nirmatrelvir/Ritonavir-Induced Calcium Channel Blocker Intoxication Successfully Treated by High Dose Insulin Therapy. [PDF]
Chen CY, Cia CT.
europepmc +1 more source
Real-world untreated risk of hospitalization and death in a nirmatrelvir/ritonavir treatment-eligible population with mild-to-moderate COVID-19 in the United States: a systematic literature review. [PDF]
Migliaccio-Walle K +9 more
europepmc +1 more source
Development of an adult whole-body PBPK model of irinotecan and its metabolites for predicting UGT1A1/CYP3A-mediated drug-drug interactions. [PDF]
Chen B +9 more
europepmc +1 more source
COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study. [PDF]
Kueper JK +11 more
europepmc +1 more source
Viral kinetics in adults with Covid-19 treated with nirmatrelvir-ritonavir or molnupiravir: a population-based, observational cohort study. [PDF]
Prager M +16 more
europepmc +1 more source
Effectiveness and safety of darunavir and lopinavir for treating children and adolescents living with HIV: a systematic review. [PDF]
O'Rourke J +10 more
europepmc +1 more source
Predicting the ritonavir crisis by revisiting the polymorph landscape with crystal structure prediction and form 4 structure solution. [PDF]
Iuzzolino L +5 more
europepmc +1 more source
Effects of Ritonavir, Lopinavir, and Alcohol on ABC Transporters and Secretion of Bile Acid and Bilirubin in Senescent Hepatocytes. [PDF]
Chen L, Duran E, Headrick D, Ji C.
europepmc +1 more source
Timeliness of switching to second-line antiretroviral therapy following virologic failure in Dar es Salaam, Tanzania. [PDF]
Thadeo MH, Bwire GM.
europepmc +1 more source
Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]
Xiong X, Chen Z, Yan B.
europepmc +1 more source

